433 related articles for article (PubMed ID: 25416277)
1. Dnmt3a loss predisposes murine hematopoietic stem cells to malignant transformation.
Mayle A; Yang L; Rodriguez B; Zhou T; Chang E; Curry CV; Challen GA; Li W; Wheeler D; Rebel VI; Goodell MA
Blood; 2015 Jan; 125(4):629-38. PubMed ID: 25416277
[TBL] [Abstract][Full Text] [Related]
2. Myeloid disorders arise in Dnmt3a-null marrow.
Delwel R
Blood; 2015 Jan; 125(4):585-6. PubMed ID: 25614634
[No Abstract] [Full Text] [Related]
3. Enforced differentiation of Dnmt3a-null bone marrow leads to failure with c-Kit mutations driving leukemic transformation.
Celik H; Mallaney C; Kothari A; Ostrander EL; Eultgen E; Martens A; Miller CA; Hundal J; Klco JM; Challen GA
Blood; 2015 Jan; 125(4):619-28. PubMed ID: 25416276
[TBL] [Abstract][Full Text] [Related]
4. Haploinsufficiency for DNA methyltransferase 3A predisposes hematopoietic cells to myeloid malignancies.
Cole CB; Russler-Germain DA; Ketkar S; Verdoni AM; Smith AM; Bangert CV; Helton NM; Guo M; Klco JM; O'Laughlin S; Fronick C; Fulton R; Chang GS; Petti AA; Miller CA; Ley TJ
J Clin Invest; 2017 Oct; 127(10):3657-3674. PubMed ID: 28872462
[TBL] [Abstract][Full Text] [Related]
5. DNMT3A Loss Drives Enhancer Hypomethylation in FLT3-ITD-Associated Leukemias.
Yang L; Rodriguez B; Mayle A; Park HJ; Lin X; Luo M; Jeong M; Curry CV; Kim SB; Ruau D; Zhang X; Zhou T; Zhou M; Rebel VI; Challen GA; Gottgens B; Lee JS; Rau R; Li W; Goodell MA
Cancer Cell; 2016 Jun; 29(6):922-934. PubMed ID: 27300438
[TBL] [Abstract][Full Text] [Related]
6. Dnmt3a loss and Idh2 neomorphic mutations mutually potentiate malignant hematopoiesis.
Zhang X; Wang X; Wang XQD; Su J; Putluri N; Zhou T; Qu Y; Jeong M; Guzman A; Rosas C; Huang Y; Sreekumar A; Li W; Goodell MA
Blood; 2020 Mar; 135(11):845-856. PubMed ID: 31932841
[TBL] [Abstract][Full Text] [Related]
7. DNA methyltransferases in hematologic malignancies.
Li KK; Luo LF; Shen Y; Xu J; Chen Z; Chen SJ
Semin Hematol; 2013 Jan; 50(1):48-60. PubMed ID: 23507483
[TBL] [Abstract][Full Text] [Related]
8. DNMT3A in haematological malignancies.
Yang L; Rau R; Goodell MA
Nat Rev Cancer; 2015 Mar; 15(3):152-65. PubMed ID: 25693834
[TBL] [Abstract][Full Text] [Related]
9. DNMT3A(R882H) mutant and Tet2 inactivation cooperate in the deregulation of DNA methylation control to induce lymphoid malignancies in mice.
Scourzic L; Couronné L; Pedersen MT; Della Valle V; Diop M; Mylonas E; Calvo J; Mouly E; Lopez CK; Martin N; Fontenay M; Bender A; Guibert S; Dubreuil P; Dessen P; Droin N; Pflumio F; Weber M; Gaulard P; Helin K; Mercher T; Bernard OA
Leukemia; 2016 Jun; 30(6):1388-98. PubMed ID: 26876596
[TBL] [Abstract][Full Text] [Related]
10. Paradoxical association of TET loss of function with genome-wide DNA hypomethylation.
López-Moyado IF; Tsagaratou A; Yuita H; Seo H; Delatte B; Heinz S; Benner C; Rao A
Proc Natl Acad Sci U S A; 2019 Aug; 116(34):16933-16942. PubMed ID: 31371502
[TBL] [Abstract][Full Text] [Related]
11. Loss of Dnmt3a and endogenous Kras(G12D/+) cooperate to regulate hematopoietic stem and progenitor cell functions in leukemogenesis.
Chang YI; You X; Kong G; Ranheim EA; Wang J; Du J; Liu Y; Zhou Y; Ryu MJ; Zhang J
Leukemia; 2015 Sep; 29(9):1847-56. PubMed ID: 25801914
[TBL] [Abstract][Full Text] [Related]
12. Alterations to
Venugopal K; Feng Y; Shabashvili D; Guryanova OA
Cancer Res; 2021 Jan; 81(2):254-263. PubMed ID: 33087320
[TBL] [Abstract][Full Text] [Related]
13. Dnmt3a regulates myeloproliferation and liver-specific expansion of hematopoietic stem and progenitor cells.
Guryanova OA; Lieu YK; Garrett-Bakelman FE; Spitzer B; Glass JL; Shank K; Martinez AB; Rivera SA; Durham BH; Rapaport F; Keller MD; Pandey S; Bastian L; Tovbin D; Weinstein AR; Teruya-Feldstein J; Abdel-Wahab O; Santini V; Mason CE; Melnick AM; Mukherjee S; Levine RL
Leukemia; 2016 May; 30(5):1133-42. PubMed ID: 26710888
[TBL] [Abstract][Full Text] [Related]
14. DNMT3A and TET2 compete and cooperate to repress lineage-specific transcription factors in hematopoietic stem cells.
Zhang X; Su J; Jeong M; Ko M; Huang Y; Park HJ; Guzman A; Lei Y; Huang YH; Rao A; Li W; Goodell MA
Nat Genet; 2016 Sep; 48(9):1014-23. PubMed ID: 27428748
[TBL] [Abstract][Full Text] [Related]
15. Decreases in different Dnmt3b activities drive distinct development of hematologic malignancies in mice.
Lopusna K; Nowialis P; Opavska J; Abraham A; Riva A; Haney SL; Opavsky R
J Biol Chem; 2021; 296():100285. PubMed ID: 33450231
[TBL] [Abstract][Full Text] [Related]
16. Loss of Dnmt3a Immortalizes Hematopoietic Stem Cells In Vivo.
Jeong M; Park HJ; Celik H; Ostrander EL; Reyes JM; Guzman A; Rodriguez B; Lei Y; Lee Y; Ding L; Guryanova OA; Li W; Goodell MA; Challen GA
Cell Rep; 2018 Apr; 23(1):1-10. PubMed ID: 29617651
[TBL] [Abstract][Full Text] [Related]
17. Hematopoietic differentiation persists in human iPSCs defective in de novo DNA methylation.
Cypris O; Franzen J; Frobel J; Glück P; Kuo CC; Schmitz S; Nüchtern S; Zenke M; Wagner W
BMC Biol; 2022 Jun; 20(1):141. PubMed ID: 35705990
[TBL] [Abstract][Full Text] [Related]
18. De novo DNA methyltransferase is essential for self-renewal, but not for differentiation, in hematopoietic stem cells.
Tadokoro Y; Ema H; Okano M; Li E; Nakauchi H
J Exp Med; 2007 Apr; 204(4):715-22. PubMed ID: 17420264
[TBL] [Abstract][Full Text] [Related]
19. Base-Resolution Analysis of DNA Methylation Patterns Downstream of
Duncan CG; Kondilis-Mangum HD; Grimm SA; Bushel PR; Chrysovergis K; Roberts JD; Tyson FL; Merrick BA; Wade PA
G3 (Bethesda); 2018 Mar; 8(3):805-813. PubMed ID: 29326230
[TBL] [Abstract][Full Text] [Related]
20. Jak2V617F and Dnmt3a loss cooperate to induce myelofibrosis through activated enhancer-driven inflammation.
Jacquelin S; Straube J; Cooper L; Vu T; Song A; Bywater M; Baxter E; Heidecker M; Wackrow B; Porter A; Ling V; Green J; Austin R; Kazakoff S; Waddell N; Hesson LB; Pimanda JE; Stegelmann F; Bullinger L; Döhner K; Rampal RK; Heckl D; Hill GR; Lane SW
Blood; 2018 Dec; 132(26):2707-2721. PubMed ID: 30366920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
